GRAND RAPIDS, Mich. (WOOD) — The University of Michigan and a research team are marking the next big step in their journey to develop noninvasive cancer treatments: a first-of-its-kind research facility.
A ribbon-cutting was held on Sept. 10 at the University of Michigan Histotripsy Center in Ann Arbor. It will cater to researchers within and from outside the university, providing access to specialized equipment and “unparalleled, inventor-level expertise” in hopes to accelerate clinical progress on histotripsy technology.
Tumor Destroyer? FDA approves tool that uses ultrasound to fight cancer
Interim U-M President Domenico Grasso believes histotripsy will be a major tool in the fight against cancer.
“Michigan is at its best when our brightest minds connect to tackle the most consequential challenges facing society,” Grasso said in a news release. “We see that today in the Histotripsy Center. Decades from now, I believe histotripsy will be spoken of alongside U-M’s historic contributions to the polio and influenza vaccines, and the many other discoveries that have defined our university’s commitment to improving and saving lives.”
WHAT IS HISTOTRIPSY?
Histotripsy is a noninvasive treatment technique developed by a U-M research team led by Dr. Zhen Xu. The name stems from the Greek terms of histo and tripsy. Histo means soft tissue and tripsy means to break down…